a:3:{s:6:"_token";s:40:"IZ98mi4IbDtvxetWPR2QUXaL3pi55s4mxA5bNXIa";s:9:"_previous";a:1:{s:3:"url";s:143:"https://www.pharmafocusasia.com/pressreleases/biomica-successfully-completes-phase-i-trial-enrollment-for-microbiome-based-immuno-oncology-drug";}s:6:"_flash";a:2:{s:3:"old";a:0:{}s:3:"new";a:0:{}}}